Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jun 2, 2026
Reporting period
Not applicable
Filed with the SEC
Jun 4, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000914190-26-000096
Filed / recorded
Jun 4, 2026, 8:28 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
BIO-TECHNE Corp
Issuer CIK
842023
Ticker
TECH
Reporting person
Steven C. Crouse
Relationship
Officer
Officer title
President - Diag & Spatial Bi
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Jun 2, 2026
Transaction code
M
Shares / units
600
Acquired / disposed
Acquired (A)
Shares owned after
6,977
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Due to a mathematical error on the Form 4 filed May 5, 2026, the number of shares beneficially owned is being increased by 40 shares and this filing represents the correct number of shares beneficially owned by the Reporting Person.
